Global Home Global Home
CANADA

 

A New Era in Anti-Infectives

 

Latest News
..........................................

December 22nd, 2008
Oculus Innovative Sciences Announces Stock Listing Remains on NASDAQ

December 3rd, 2008
Oculus Innovative Sciences Announces Vetericyn(TM) Wound Spray for Animals to be Distributed in over 1,000 PetSmart Stores

December 1st, 2008
Oculus Innovative Sciences Announces Agreement with Bayer Taiwan Co. Ltd. for Development of Microcyn(R) Technology Use in Taiwanese Animal Market

November 25th, 2008
Oculus Innovative Sciences Receives NASDAQ Notification

November 5th, 2008
Oculus Innovative Sciences Reports Record Second Quarter Product Revenue Up 81%

November 3rd, 2008
Oculus Innovative Sciences to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11

October 29th, 2008
Oculus Innovative Sciences Announces Fiscal Second Quarter Financial Results and Corporate Update Release and Conference Call

October 28th, 2008
Oculus Innovative Sciences Introduces Microcyn(R) Wound Care OTC for U.S. Consumer Market

October 21st, 2008
Oculus Innovative Sciences Launches Microcyn(R) Wound Care for U.S. Podiatry Market

October 8th, 2008
Oculus Innovative Sciences Provides Clinical and Business Update

More »

..........................................

 

Wound Care, Dermacyn, Microcyn Technology


Oculus Innovative Sciences is pioneering innovative sciences resulting in breakthrough advances in technology. The revolutionary Microcyn® Technology, the company’s first commercialized technology, is now available in various formulations in the Canada.

Dermacyn Wound Care

Dermacyn® Wound Care
Dermacyn® Wound Care is a super-oxidized solution for moistening, lubricating, cleaning and debriding acute and chronic wounds including stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post surgical wounds, burns, abrasions and minor irritations of the skin.